SynthesisBMC gastroenterology2026
Sessile serrated lesions of the appendix: a contemporary review of the literature.
Synthesis in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSessile serrated lesions (SSLs) of the appendix remain a controversial entity due to evolving definitions, diagnostic criteria, and nomenclature. Shifts in diagnostic thresholds - from multiple serrated crypts to a single unequivocally serrated and distorted crypt - have led to discrepancies in lesion classification and retrospective analyses. These controversies, compounded by inconsistent adherence to updated criteria, highlight the need for studies and reviews applying contemporary standards to accurately assess incidence and clinical significance.
methodsThe review protocol was registered in PROSPERO (CRD420261299191). Systematic searches of PubMed, Web of Science, Scopus and Ovid were performed for studies published between 2007 and 2025. Eligible studies reporting clinicopathological features of appendiceal SSLs were included.
resultsThe reported prevalence of appendiceal SSLs is low (approximately 1.11-5.22‰), but increases with age and is markedly higher in patients with serrated polyposis syndrome. Most lesions are incidentally detected histologically, are often macroscopically inconspicuous, and show dysplasia in a minority of cases (~ 28%). Compared with colonic SSLs, appendiceal lesions are less common, show female predominance, and more frequently harbour KRAS rather than BRAF mutations, suggesting partially distinct molecular pathways. Although occasional co-occurrence with mucinous neoplasms and adenocarcinoma may suggest possible biological links, current evidence is insufficient to define a consistent progression pathway or establish their true malignant potential.
conclusionsOverall, the current literature is constrained by small sample sizes, heterogeneous study designs, inconsistent reporting, and substantial publication bias, particularly toward unusual or concurrent neoplastic findings. These limitations preclude definitive conclusions regarding the true prevalence, natural history, and malignant potential of appendiceal SSLs. Further large-scale, systematically characterised, and longitudinally followed cohorts with comprehensive molecular profiling are required to clarify their biological behaviour and clinical significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.